Table 2.
Outcome | Index Date Treatment | Number of Events | Person‐Year (PY) | Unadjusted Incidence Rate *100,000 PY | Lower 95% Confidence Limit | Upper 95% Confidence Limit |
---|---|---|---|---|---|---|
Unspecified intestinal Malabsorptiona | Olmesartan | 1 | 32,041 | 3.12 | 0.44 | 22.16 |
Other ARBs | 12 | 136,827 | 8.77 | 4.98 | 15.44 | |
ACE‐i | 10 | 431,139 | 2.32 | 1.25 | 4.31 | |
Intestinal malabsorptionb | Olmesartan | 4 | 32,035 | 12.49 | 4.69 | 33.27 |
Other ARBs | 20 | 136,818 | 14.62 | 9.43 | 22.66 | |
ACE‐i | 39 | 431,123 | 9.05 | 6.61 | 12.38 |
ACE‐i indicates angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker.
ICD‐10: K90.4, K90.8, K90.9; ICD‐9:579.8, 579.9.
ICD‐10: K90.x; ICD‐9: 579.x.